BRAT 2 Autologous Blood Recovery System

Products	BRAT 2 Autologous Blood Recovery System
Company	Sorin Group USA, Inc.
Item	BRAT 2 Autologous Blood Recovery System
Features	Dedicated processing keys to start processing quickly and easily Built-in reservoir holder eliminates the need for additional holder Flat, clear lid with safety lock provides visibility of the bowl and a flat writing surface Smaller profile fits well in any size operating room Storage area for additional supplies Three position wheel locking mechanism maximizes mobility Easy to load disposables snap correctly into place without hassle Automatic re-pack feature removes excessive plasma free hemoglobin and ensures proper bowl filling Patented Baylor Bowl provides a high hematocrit and fast processing
Description	BRAT 2 Autologous Blood Recovery System gives performance, speed, versatility, and quality processing. The BRAT 2 is now available with on-board Vacuum, programmability, plasma sequestration, Data Output System, and in the CRIT LINE.
Info	Sorin Group USA, Inc. Customer Service: (800) 221-7943 Web site: http://www.sorin-na.com/index.html

TAG: BRAT Autologous Blood Recovery System

The 15 and 18 Sony Flat Screen Monitors with articulating arm can be used in conjunction with existing surgical monitors or as replacements.

Colour video monitors.

The A3 3-Chip Camera includes digital processing, seamless autoshutter, industry-leading reliability, white balance with memory function, ease of operation, and a 2 year warranty.

Camera and light source in one compact "Plug-and-Play" device.

Medicine Products:

Sony Flat Panel Displays with C3269 Articulating Arm Sony PVM A3 3-Chip Camera 1CCD ENDOCAM LIGHT 5551

(Date:9/5/2008)...pt. 5 /PRNewswire-USNewswire/ -- As the general el...nal Federation of Independent,Business ( http://ww...ndidates for a greater focus on the healthcare con...nd Republican conventions are over, NFIB,is asking... obstacles faced,by small businesses as they furth...

(Date:9/5/2008)...men with hormone-receptor positive, metastatic bre...keep their cancer at bay, but when the tumor becom...h chemotherapy becomes the only option. But a stud...ymposiummay change this approach. Early data sugg...he tumor, allowing anti-hormonal drugs to do their...

(Date:9/4/2008)....C. Free drug samples provided to physicians by p...uninsured patients more in the long run, according...versity Baptist Medical Center and colleagues. , ... habits of more than 70 physicians in a university...hs immediately before and after the closing of the...

(Date:9/4/2008)...quence of instructions they say could help doctors...ealthDay News) -- Vaccine safety experts say that ...eceive vaccinations with close monitoring and a se...September issue of Pediatrics , a team of experts...rth a step-by-step set of instructions -- an algor...

Breaking Medicine News(10 mins):Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 2 Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 3 Health News:1 step back ... 2 steps forward 2 Health News:Free drug samples may end up costing uninsured more 2 Health News:Free drug samples may end up costing uninsured more 3 Health News:Even Kids With Known Allergies Can Be Safely Vaccinated 2

[0] Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns [0] 1 step back ... 2 steps forward [0] Free drug samples may end up costing uninsured more [0] Even Kids With Known Allergies Can Be Safely Vaccinated

...cted by the researchers at the Loughborough Univer...ool children could affect //the children psycholog...o create awareness about childhood obesity the gov...easure children's body mass index (BMI). But the ...

...ing on HIV tests ahead of marriages. // Pathology...he number of HIV tests, particularly during the ma... HIV test done last year. "I was in love with he...ts thought I was a flirt," said Bose. "But when I ...

...son has alleged that medical records of patients t... that could cost the life of a patient. //Many NHS... India to save costs, the union said. However som...hich means high blood pressure, instead of "hypote...

...oped at selected medical centers successfully trea...ain. // Motor cortex stimulation a new experiment...nt or intermittent pain rather than believing on t...hysical therapy. Electrodes, when placed over the...

Other Medicine News:

Study Says Screening of Children's Weight in Schools Would Put Them under Pressure HIV Test is Becoming Mandatory as a Part of Pre-marriage Exercise Outsourcing Medical Records Risky: Unison Chronic Facial Pain Tackled By Cortex Stimulation

(Date:9/3/2008)...Focuses Operations, Updates Zingo Launch Progress ...ategy Conference Call Today at 11...- Anesiva,Inc. (Nasdaq: A...cture,operations to focus on commercial and late-s...ion to a specialty pharmaceutical pain management,...

(Date:9/3/2008)...to be Evaluated in Repeat-Dosing Study in Subjects...FirstCall/ -- Sangamo,BioSciences, Inc. (Nasdaq: ...2 clinical trial (SB-509-801) to evaluate its drug...enerative motor-neuron disease for which there,are...s drug, SB-509, is an injectable formulation of a ...

(Date:9/2/2008)..., Sept. 3 /- Forest Laborat...l, S.A. today announced results from,two global Ph...g-acting,inhaled anticholinergic for the treatment...sease (COPD). In both the ACCLAIM/COPD I&II,(AClid... In Moderate to,Severe COPD Patients) studies, onc...

(Date:9/2/2008)...gates Join World Vision, ONE to Build Hope and Giv...re/ -- Delegates to the,Republican Party Conventio...munities around the world including evacuees in th...nd AIDS in developing countries: "We are here,to h...ting party delegates to do,something unconventiona...

Breaking Medicine Technology:Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2 Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3 Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4 Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6 Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 2 Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 3 Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 4 Scientists 3A New technique identifies molecular biomarkers for disease 15546 1 Scientists 3A New technique identifies molecular biomarkers for disease 15546 2 Scientists 3A New technique identifies molecular biomarkers for disease 15546 3 See More Do More 3A Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 15541 1 See More Do More 3A Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 15541 2 See More Do More 3A Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 15541 3 See More Do More 3A Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 15541 4 Blue Cross Consumer directed Health Plan Options Blue Members Not Sacrificing Health for the Sake of Saving Money 15536 1 Blue Cross Consumer directed Health Plan Options Blue Members Not Sacrificing Health for the Sake of Saving Money 15536 2 Blue Cross Consumer directed Health Plan Options Blue Members Not Sacrificing Health for the Sake of Saving Money 15536 3 ExonHit Appoints a New Management Board 4283 1 ExonHit Appoints a New Management Board 4283 2 ExonHit Appoints a New Management Board 4283 3 ExonHit Appoints a New Management Board 4283 4

[0] Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company [0] Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)[0] Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)[0] Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees

...e Showed Substantial,Reduction of Disease Activity...ple Sclerosis , Combination Treatment With Antibio...erated , KANSAS CITY, Mo, May 4, 2007 - New data f... combination of Copaxone,(glatiramer acetate injec...educed T1 Gadolinium (Gd)-enhancing lesions of the...

...S Pharmaceuticals plc,(LSE: CEN), the Cambridge ba...on of an independent study in the respected scient...onist, CNS 5161. CeNeS,is developing CNS 5161 as a...ependent study builds on the work that CeNeS has,a...ported in ,Synapse, Dr Anat Biegon and her group,...

Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis Independent publication supports the profile of CeNeS phase II,compound, CNS 5161